PB Fintech, the parent company of Policybazaar, has invested Rs 539.4 crore in its healthcare subsidiary, PB Healthcare Services, marking the beginning of a larger Rs 1,461.6 crore seed funding round that includes external investors.
This initial investment was made through the subscription of 5.39 crore Compulsory Convertible Preference Shares (CCPS) at Rs 100 apiece, as disclosed by the company in a regulatory filing to the stock exchanges.
The funding round also includes the creation of an employee stock option plan (ESOP) pool. Following the completion of all allotments under this round, PB Fintech’s ownership in the healthcare subsidiary will drop from 100% to 32.14% on a fully diluted basis.
PB Fintech said the dilution was part of a broader strategic plan to “bring in external investors and create an ESOP pool to attract and retain talent.”
.thumbnailWrapper{
width:6.62rem !important;
}
.alsoReadTitleImage{
min-width: 81px !important;
min-height: 81px !important;
}
.alsoReadMainTitleText{
font-size: 14px !important;
line-height: 20px !important;
}
.alsoReadHeadText{
font-size: 24px !important;
line-height: 20px !important;
}
}
PB Fintech had earlier announced plans to invest Rs 696 crore in PB Healthcare Services, its dedicated healthcare arm, to accelerate growth in the sector. The move had been approved by the company’s board in a meeting held in March 2025, according to a regulatory filing.
Following that investment plan, PB Fintech was expected to hold up to 33.63% of PB Healthcare’s equity on a fully diluted basis, alongside contributions from CEO Yashish Dahiya, Executive Vice Chairman Alok Bansal, three senior managerial executives, and external investors. The final equity structure was contingent on the actual amounts invested.
PB Healthcare Services, incorporated in January 2025, had set out with the goal of establishing hospitals with a cumulative capacity of 1,000 beds within the first year. Initial operations were planned in the National Capital Region (NCR), with a roadmap to expand into other metro cities.
Funds from the initial infusion were earmarked for general operational expenses, brand awareness campaigns, office expansions, and other strategic initiatives.
Edited by Kanishk Singh
